#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14664	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2086	698.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	842	C,T,A	798,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26298	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3445	760.2	0	.	n	.	0	T695C	SNP	695	695	T	969	969	C	812	C,T	757,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26298	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3445	760.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1912	1912	G	795	G	758	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26298	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3445	760.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2245	2245	C	864	C,T	813,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26298	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3445	760.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2319	2319	A	855	A	811	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26298	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3445	760.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2871	2871	C	782	C	738	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2114	folP	855	855	100.0	folP.l15.c17.ctg.1	1496	140.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1037	1039	AGC	222;224;225	A;G;C	209;210;211	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	156.7	1	SNP	p	S91F	1	.	.	271	273	TTC	620	622	TTC	168;164;167	T;T;C,T	159;157;157,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	156.7	1	SNP	p	D95G	1	.	.	283	285	GGC	632	634	GGC	170;168;167	G;G;C	159;156;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	156.7	1	SNP	p	G95N	0	.	.	283	285	GGC	632	634	GGC	170;168;167	G;G;C	159;156;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1758	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1373	127.5	0	.	p	.	0	D79N	NONSYN	235	237	GAT	594	596	AAT	218;216;214	A;A;T	206;206;202	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1758	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1373	127.5	1	SNP	p	G45D	0	.	.	133	135	GGC	492	494	GGC	234;236;236	G;G;C	219;218;222	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	880	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	989	88.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2897	184.4	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	213;210;209	G;A;C	199;192;197	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2897	184.4	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	204;205;207	C,T,A;G;T	188,1,1;192;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2897	184.4	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	204;205;207	C,T,A;G;T	188,1,1;192;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2897	184.4	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	204;205;207	C,T,A;G;T	188,1,1;192;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2897	184.4	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	205;207;207	T;C;C	189;193;195	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4406	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2656	165.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1526	1528	GGC	190;187;184	G;G;C	178;174;169	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1293	1295	GCA	184;181;180	G,T;C;A	175,1;173;171	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1296	1298	ATC	179;179;180	A;T,C;C	169;169,1;166	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1308	1310	GTG	196;194;195	G;T;G	183;184;186	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1308	1310	GTG	196;194;195	G;T;G	183;184;186	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1812	1814	ACC	186;187;187	A;C;C	179;177;179	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1866	1868	GCG	190;193;192	G;C,G;G,A	164;154,1;159,2	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1866	1868	GCG	190;193;192	G;C,G;G,A	164;154,1;159,2	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1989	1991	AGC	166;169;169	A;G;C	154;154;158	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1998	2000	GGC	176;175;173	G;G;C	163;161;158	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3998	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2352	169.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2016	2018	CCG	158;159;159	C,G;C;G	118,4;120;122	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5564	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3018	183.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1561	1563	CCG	187;188;188	C;C;G	165;171;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2282	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1790	126.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	144	C	135	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	410	412	GGA	213;212;215	G;G;A	198;197;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	533	535	AGC	223;224;224	A;G;C	199;203;196	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	625	626	CG	215;222	C;G	199;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	628	630	CAG	218;218;217	C,T;A,G;G,C	198,1;200,1;200,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	632	634	AAA	215;215;215	A;A;A,C	199;199;199,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	659	661	TAT	219;214;212	T;A;T,C	201;198;195,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	N134E	NONSYN	400	402	AAT	668	670	GAG	213;214;215	G;A;G	198;199;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	V135F	NONSYN	403	405	GTG	671	673	TTT	215;216;219	T,G;T;T	196,1;200;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	686	688	AAA	222;220;218	A;A;A	206;208;206	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	695	697	GAA	208;209;207	G;A;A	197;195;195	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	719	721	GCA	208;210;212	G;C;A	196;194;195	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	827	829	CAA	192;192;194	C;A;A	186;185;186	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	N189S	NONSYN	565	567	AAC	833	835	AGC	191;189;190	A;G;C,T	184;182;183,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	G211E	NONSYN	631	633	GGA	899	901	GAA	182;177;175	G,C;A;A	171,1;169;169	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	902	902	T	176	T	167	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	1	SNP	p	G120K	1	.	.	358	360	AAG	625	627	CGG	215;222;217	C;G;G	199;203;201	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	1	SNP	p	D121N	0	.	.	361	363	GAC	628	631	CGC	218;217;215	C,T;G,C;C	198,1;200,1;199	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2486	porB1b	1041	1041	95.72	porB1b.l15.c4.ctg.1	1463	169.0	1	SNP	p	A121D	1	.	.	361	363	GAC	628	631	CGC	218;217;215	C,T;G,C;C	198,1;200,1;199	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9956	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4839	205.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1156	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1042	110.3	1	SNP	p	V57M	1	.	.	169	171	ATG	547	549	ATG	222;225;224	A;T;G	215;216;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
